Related Experiment Video
Updated: Nov 23, 2025

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma
Published on: June 2, 2023
Medicinal Mushrooms for Treatment of Type 2 Diabetes: An Update on Clinical Trials
Ulrike Lindequist1, Beate Haertel1
1Institute of Pharmacy, Pharmaceutical Biology, University of Greifswald, Institute of Pharmacy, Ernst-Moritz-Arndt University of Greifswald, Friedrich-Ludwig-Jahn Str. 17, D-17489 Greifswald, Germany.
Abstract:
Several medicinal mushrooms exhibit hypoglycaemic activities in vitro and in animal studies. In contrast to the high number of experimental results, only a few clinical trials and/or case reports have been published. They exist for mushrooms of the genera Agaricus, Coprinus, Ganoderma, Grifola, and Pleurotus. This article critically reviews these clinical investigations and describes which tasks need to be done to explore the potential of mushrooms for supportive treatment of type 2 diabetes.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Clinical Trials: Overview
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

